Holen Sie sich die Stockscreener-App
48.11
8.21%
3.65
Handel nachbörslich:
47.98
-0.13
-0.27%
Hims Hers Health Inc Aktie (HIMS) Neueste Nachrichten
Eli Lillys 036 Gains Overshadowed by 3075 Volume Drop as Court Dismisses Lawsuit Stock Ranks 33rd in Market Activity Amid Hims Surge - AInvest
Strategic Capital Moves in Disruptive Consumer & Mobility Sectors: Lyft, Hims & Hers, and Constellation Brands - AInvest
Noteworthy Wednesday Option Activity: HIMS, UNH, SMMT - Nasdaq
Lyft convertible notes, Hims & Hers surges, Constellation Brands - Yahoo Finance
Hims & Hers Health Stock (HIMS) Opinions on Telehealth Innovation and Recent Setbacks - Quiver Quantitative
Hims & Hers gains after court rejects Eli Lilly’s case against Willow - Yahoo Finance
Hims & Hers Health Set to Meet Revenue Projections Amid Growing Confidence - StocksToTrade
Hims & Hers Sees Revenue Growth Amid Deutsche Bank’s Optimistic Outlook - timothysykes.com
Hers Health Inc.Weekly Market Report & Community Consensus Picks - Newser
Here is What to Know Beyond Why Hims & Hers Health, Inc. (HIMS) is a Trending Stock - Yahoo Finance
Hers Health Inc. in sector analysis2025 Institutional Moves & Long-Term Safe Investment Ideas - Newser
HIMS' Personalized Wellness Platform Expands Preventive Care Access - sharewise.com
Hers Health Inc. holdersBond Market & Long-Term Growth Portfolio Plans - Newser
Hers Health Inc. reversing from oversold territoryLayoff News & Accurate Buy Signal Notifications - Newser
Hims & Hers Health: Still Undervalued (NYSE:HIMS) - Seeking Alpha
Hers Health Inc. stock trend forecastRisk Management & Reliable Volume Spike Trade Alerts - Newser
Hers Health Inc. bounce back from current support2025 Price Targets & AI Enhanced Trading Signals - Newser
Insider Moves: Datadog, Hims & Hers, Opendoor, Texas Instruments, Vertiv - TipRanks
Hers Health Inc.’s reversalGap Down & Stock Timing and Entry Methods - Newser
Hims & Hers: The Dominant Health Platform Of The Future (NYSE:HIMS) - Seeking Alpha
Real time social sentiment graph for HIMSNew Guidance & Safe Entry Trade Reports - Newser
Hers Health Inc. stock entering bullish territoryTrade Exit Report & Growth Focused Entry Reports - Newser
Hims & Hers Climbs to 102nd in Market Activity With $790M Volume as Insider Sales and Mixed Earnings Spark Doubts - AInvest
Hims & Hers Health Insider Selling: Signal of Distrust or Strategic Rebalancing? - AInvest
Hers Health Inc. in the next 30 daysPortfolio Growth Summary & Weekly Top Gainers Alerts - Newser
HIMS vs. AMWL: Which Stock Has the Stronger Global Growth Strategy? - The Globe and Mail
Hims & Hers Health Stock Plunges 2.95% as Trading Volume Falls 32% to $890M and Drops to 67th in Activity - AInvest
Hims & Hers’ growth prospects clouded by Novo dispute and regulatory scrutiny - S&P Global
HIMS & HERS ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
Hims & Hers Scales Growth Through Subscriptions and Care Expansion - sharewise.com
Hims & Hers Health Is Looking to Cash In on This Novo Nordisk Blunder - ca.finance.yahoo.com
Hims & Hers Health Clears Key Benchmark, Hitting 90-Plus RS Rating - Investor's Business Daily
Hers Health Inc. stock performanceQuarterly Trade Review & Daily Growth Stock Investment Tips - Newser
Hims & Hers Stocks: Join the Pharma Boom? - StocksToTrade
Hims & Hers Health Stock (HIMS) Opinions on Telehealth Disruption and Recent Challenges - Quiver Quantitative
Hims & Hers Health Surges 5.15% on Intraday Rally—What’s Fueling the Momentum? - AInvest
Hims & Hers' Resilience Amid GLP-1 Market Shifts: Short-Term Volatility vs. Long-Term Personalized Care Positioning - AInvest
Hims & Hers Health, Inc. Class Action: Levi & Korsinsky - GlobeNewswire
Hims & Hers: Navigating Short-Sellers and Regulatory Storms in the DTC Healthcare Sector - AInvest
Levi & Korsinsky Helps Shareholders SueWallSt After Hims & Hers Health, Inc. Stock Drops - Stockhouse
Hims & Hers Health: Navigating Regulatory Storms and Rebuilding a Growth Narrative - AInvest
Hims & Hers: A Case Study in Governance and Partnership Risks in the Digital Health Sector - AInvest
Rocket, Oscar, Hims & Hers: Short Sellers Are Playing With Fire - Benzinga
Did You Lose Money on Hims & Hers Health, Inc. (HIMS)? Levi & Korsinsky Urges Investors to Act Before August 25, 2025 - ACCESS Newswire
Discounted Ozempic Could Deflate ETF Optimism Around Hims & Hers - Benzinga
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health - Business Wire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - GlobeNewswire Inc.
DEADLINE ALERT for HIMS, IRBT, and CNC: The Law Offices of - GlobeNewswire
Hims & Hers Health, Inc. Sued for Securities Law ViolationsContact The Gross Law Firm Before August 25, 2025 to Discuss Your RightsHIMS - PR Newswire
Is Regulatory Scrutiny and Novo Nordisk Partnership Loss Changing the Investment Case for Hims & Hers Health (HIMS)? - Yahoo Finance
Top 3 US Digital Health Stocks That are Leading the Healthcare Revolution - The Smart Investor
Investors in Hims & Hers Health, Inc. (HIMS): Protect Your RightsContact Levi & Korsinsky Before August 25, 2025 - ACCESS Newswire
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Morningstar
Hims & Hers Health, Inc. Investigated for Securities Fraud ViolationsContact the DJS Law Group to Discuss Your RightsHIMS - MarketScreener
Lost Money on Hims & Hers Health, Inc. (HIMS)? Contact Levi & Korsinsky to Join Class Action Before August 25, 2025 - Newsfile
2.74%
4.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):